Our results indicate that PSMA-1-MMAE-Pc413 traverses through the cancer vasculature and that PDT activity from the Pc413 portion of the molecule allows the destruction of these tumor-associated structures upon the application of NIR light, leading to more drug accumulation in the tumor after the second injection as indicated with fluorescence imaging (Figure 5A). This evidence concerns the gene FOLH1 and neoplasm.